- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Vaccine Adjuvants market will register a 10.6% CAGR in terms of revenue, the global market size will reach $ 1004 million by 2025, from $ 671.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vaccine Adjuvants business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by type, application, key manufacturers and key regions and countries.
This study considers the Vaccine Adjuvants value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Subcutaneous
Intramuscular
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
SEPPIC
GSK
SDA BIO
SPI Pharma
Phibro Animal Health Corporation
Croda International Plc
Zhuoyue
Tj Kaiwei
Aphios
Novavax
Avanti Polar Lipids
Aphios
CSL Limited
SPI Pharma
SEPPIC
Novavax
Brenntag Biosector
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vaccine Adjuvants consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vaccine Adjuvants market by identifying its various subsegments.
Focuses on the key global Vaccine Adjuvants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccine Adjuvants with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vaccine Adjuvants submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Consumption 2015-2025
2.1.2 Vaccine Adjuvants Consumption CAGR by Region
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Vaccine Adjuvants Consumption by Type
2.3.1 Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2015-2020)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
2.4.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
2.5 Vaccine Adjuvants Consumption by Application
2.5.1 Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
2.5.2 Global Vaccine Adjuvants Value and Market Share by Type (2015-2020)
2.5.3 Global Vaccine Adjuvants Sale Price by Type (2015-2020)
3 Global Vaccine Adjuvants by Company
3.1 Global Vaccine Adjuvants Sales Market Share by Company
3.1.1 Global Vaccine Adjuvants Sales by Company (2018-2020)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2018-2020)
3.2 Global Vaccine Adjuvants Revenue Market Share by Company
3.2.1 Global Vaccine Adjuvants Revenue by Company (2018-2020)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2018-2020)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Global Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vaccine Adjuvants Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccine Adjuvants by Regions
4.1 Vaccine Adjuvants by Regions
4.2 Americas Vaccine Adjuvants Consumption Growth
4.3 APAC Vaccine Adjuvants Consumption Growth
4.4 Europe Vaccine Adjuvants Consumption Growth
4.5 Middle East & Africa Vaccine Adjuvants Consumption Growth
5 Americas
5.1 Americas Vaccine Adjuvants Consumption by Countries
5.1.1 Americas Vaccine Adjuvants Consumption by Countries (2015-2020)
5.1.2 Americas Vaccine Adjuvants Value by Countries (2015-2020)
5.2 Americas Vaccine Adjuvants Consumption by Type
5.3 Americas Vaccine Adjuvants Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vaccine Adjuvants Consumption by Regions
6.1.1 APAC Vaccine Adjuvants Consumption by Regions (2015-2020)
6.1.2 APAC Vaccine Adjuvants Value by Regions (2015-2020)
6.2 APAC Vaccine Adjuvants Consumption by Type
6.3 APAC Vaccine Adjuvants Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vaccine Adjuvants by Countries
7.1.1 Europe Vaccine Adjuvants Consumption by Countries (2015-2020)
7.1.2 Europe Vaccine Adjuvants Value by Countries (2015-2020)
7.2 Europe Vaccine Adjuvants Consumption by Type
7.3 Europe Vaccine Adjuvants Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Adjuvants by Countries
8.1.1 Middle East & Africa Vaccine Adjuvants Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vaccine Adjuvants Value by Countries (2015-2020)
8.2 Middle East & Africa Vaccine Adjuvants Consumption by Type
8.3 Middle East & Africa Vaccine Adjuvants Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine Adjuvants Distributors
10.3 Vaccine Adjuvants Customer
11 Global Vaccine Adjuvants Market Forecast
11.1 Global Vaccine Adjuvants Consumption Forecast (2021-2025)
11.2 Global Vaccine Adjuvants Forecast by Regions
11.2.1 Global Vaccine Adjuvants Forecast by Regions (2021-2025)
11.2.2 Global Vaccine Adjuvants Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vaccine Adjuvants Forecast by Type
11.8 Global Vaccine Adjuvants Forecast by Application
12 Key Players Analysis
12.1 SEPPIC
12.1.1 Company Information
12.1.2 Vaccine Adjuvants Product Offered
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 SEPPIC Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Vaccine Adjuvants Product Offered
12.2.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 SDA BIO
12.3.1 Company Information
12.3.2 Vaccine Adjuvants Product Offered
12.3.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 SDA BIO Latest Developments
12.4 SPI Pharma
12.4.1 Company Information
12.4.2 Vaccine Adjuvants Product Offered
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 SPI Pharma Latest Developments
12.5 Phibro Animal Health Corporation
12.5.1 Company Information
12.5.2 Vaccine Adjuvants Product Offered
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Phibro Animal Health Corporation Latest Developments
12.6 Croda International Plc
12.6.1 Company Information
12.6.2 Vaccine Adjuvants Product Offered
12.6.3 Croda International Plc Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Croda International Plc Latest Developments
12.7 Zhuoyue
12.7.1 Company Information
12.7.2 Vaccine Adjuvants Product Offered
12.7.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Zhuoyue Latest Developments
12.8 Tj Kaiwei
12.8.1 Company Information
12.8.2 Vaccine Adjuvants Product Offered
12.8.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Tj Kaiwei Latest Developments
12.9 Aphios
12.9.1 Company Information
12.9.2 Vaccine Adjuvants Product Offered
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Aphios Latest Developments
12.10 Novavax
12.10.1 Company Information
12.10.2 Vaccine Adjuvants Product Offered
12.10.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Novavax Latest Developments
12.11 Avanti Polar Lipids
12.11.1 Company Information
12.11.2 Vaccine Adjuvants Product Offered
12.11.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Avanti Polar Lipids Latest Developments
12.12 Aphios
12.12.1 Company Information
12.12.2 Vaccine Adjuvants Product Offered
12.12.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aphios Latest Developments
12.13 CSL Limited
12.13.1 Company Information
12.13.2 Vaccine Adjuvants Product Offered
12.13.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 CSL Limited Latest Developments
12.14 SPI Pharma
12.14.1 Company Information
12.14.2 Vaccine Adjuvants Product Offered
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SPI Pharma Latest Developments
12.15 SEPPIC
12.15.1 Company Information
12.15.2 Vaccine Adjuvants Product Offered
12.15.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 SEPPIC Latest Developments
12.16 Novavax
12.16.1 Company Information
12.16.2 Vaccine Adjuvants Product Offered
12.16.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Novavax Latest Developments
12.17 Brenntag Biosector
12.17.1 Company Information
12.17.2 Vaccine Adjuvants Product Offered
12.17.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Brenntag Biosector Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Vaccine Adjuvants Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of O
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
